We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

468 hedge funds and large institutions have $3.48B invested in iShares US Medical Devices ETF in 2020 Q2 according to their latest regulatory filings, with 138 funds opening new positions, 194 increasing their positions, 75 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

345% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 31

159% more repeat investments, than reductions

Existing positions increased: 194 | Existing positions reduced: 75

98% more capital invested

Capital invested by funds: $1.76B → $3.48B (+$1.72B)

57.85% more ownership

Funds ownership: 253.69%311.54% (+58%)

35% more funds holding in top 10

Funds holding in top 10: 1723 (+6)

29% more funds holding

Funds holding: 364468 (+104)

84% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $69.5M

Holders
468
Holders Change
+104
Holders Change %
+28.57%
% of All Funds
9.6%
Holding in Top 10
23
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+35.29%
% of All Funds
0.47%
New
138
Increased
194
Reduced
75
Closed
31
Calls
$10.8M
Puts
$69.5M
Net Calls
-$58.7M
Net Calls Change
-$50.3M
Name Holding Trade Value Shares
Change
Change in
Stake
CFA
301
Carroll Financial Associates
North Carolina
$461K +$64.9K +1,518 +17%
CFA
302
Cahill Financial Advisors
Minnesota
$451K +$35.9K +840 +9%
TCWM
303
Total Clarity Wealth Management
Illinois
$445K +$10.3K +240 +2%
IFWM
304
Institute for Wealth Management
Colorado
$443K +$34.6K +810 +9%
PPP
305
Private Portfolio Partners
New Jersey
$441K +$427K +9,984 New
Northern Trust
306
Northern Trust
Illinois
$425K +$411K +9,612 New
CA
307
Cornerstone Advisory
Maryland
$424K +$51.3K +1,200 +14%
WAS
308
WESPAC Advisors SoCal
California
$419K +$85.9K +2,010 +27%
VNA
309
Valley National Advisers
Pennsylvania
$415K +$11.8K +276 +3%
IF
310
Intrua Financial
Texas
$413K +$358K +8,382 New
DADC
311
D.A. Davidson & Co
Montana
$412K +$399K +9,336 New
WA
312
WP Advisors
California
$405K +$256 +6 +0.1%
TC
313
TownSquare Capital
Utah
$400K -$151K -3,534 -28%
SAM
314
Seelaus Asset Management
New Jersey
$400K -$38.5K -900 -9%
CS
315
Credit Suisse
Switzerland
$399K -$352K -8,238 -48%
SEI Investments
316
SEI Investments
Pennsylvania
$397K
Rockefeller Capital Management
317
Rockefeller Capital Management
New York
$394K +$98.5K +2,304 +35%
TSS
318
Two Sigma Securities
New York
$394K +$382K +8,928 New
JIP
319
Jaffetilchin Investment Partners
Florida
$393K -$341K -7,980 -47%
IFS
320
Ifrah Financial Services
Arkansas
$385K -$13.3K -312 -3%
AWE
321
Avidian Wealth Enterprises
Texas
$385K +$373K +8,718 New
SEIA
322
Signature Estate & Investment Advisors
California
$377K +$365K +8,538 New
RWMH
323
Riverpoint Wealth Management Holdings
Illinois
$371K
1832 Asset Management
324
1832 Asset Management
Ontario, Canada
$370K -$167K -3,906 -31%
JSC
325
Jackson Square Capital
California
$361K -$160K -3,744 -31%

IHI Hedge Fund Activity: Q2 2020 in Review

468 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2020, worth a combined $3.48B — up 98% from $1.76B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new IHI positions and 31 closed out — a net gain of 107 holders — while 194 added to existing stakes and 75 trimmed.

The largest buyer was Envestnet Asset Management, adding an estimated $412M. The largest seller was Goldman Sachs, cutting an estimated $83M.

  • 468 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2020, up from 364 in Q1 2020.
  • Funds reported $3.48B of iShares US Medical Devices ETF stock for Q2 2020, up 98% quarter-over-quarter.
  • 138 funds opened new iShares US Medical Devices ETF positions in Q2 2020 and 31 closed out, a net change of +107 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2020 was Envestnet Asset Management, an estimated $412M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2020 was Goldman Sachs, an estimated $83M sold.

Based on aggregated 13F filings for Q2 2020.